Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso.

MLA

Rouamba, Toussaint, et al. “Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso.” Drug Design, Development and Therapy, vol. 14, Apr. 2020, pp. 1507–21. EBSCOhost, https://doi.org/10.2147/DDDT.S224857.

APA

Rouamba, T., Sondo, P., Derra, K., Nakanabo-Diallo, S., Bihoun, B., Rouamba, E., Tarnagda, Z., Kazienga, A., Valea, I., Sorgho, H., Pagnoni, F., Samadoulougou-Kirakoya, F., & Tinto, H. (2020). Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso. Drug Design, Development and Therapy, 14, 1507–1521. https://doi.org/10.2147/DDDT.S224857

Chicago

Rouamba, Toussaint, Paul Sondo, Karim Derra, Seydou Nakanabo-Diallo, Biebo Bihoun, Eli Rouamba, Zekiba Tarnagda, et al. 2020. “Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso.” Drug Design, Development and Therapy 14 (April): 1507–21. doi:10.2147/DDDT.S224857.